ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 41311809

Discovery of PAK2 as a Key Regulator of Cancer Stem Cell in Head and Neck Squamous Cell Carcinoma Using Multi-Omic Techniques.

Wang P and 3 others. Stem Cells Int, 2025. Cited by 40 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Discovery of PAK2 as a Key Regulator of Cancer Stem Cell in Head and Neck Squamous Cell Carcinoma Using Multi-Omic Techniques. Papers, record 41311809. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41311809

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Discovery of PAK2 as a Key Regulator of Cancer Stem Cell in Head and Neck Squamous Cell Carcinoma Using Multi-Omic Techniques.
PubMed
Journal
Stem Cells Int
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
40
iCite
Relative citation ratio, by iCite
10.24, provisional
iCite
Revised in PubMed
2025-11-30
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang PPuyuhttps://orcid.org/0009-0001-3431-2315
2Xu SShengshanhttps://orcid.org/0000-0003-3371-7780
3Guo QQianhttps://orcid.org/0009-0009-7398-709X
4Zhao YYulinhttps://orcid.org/0009-0004-2886-8175

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
140,179,586Programmed cell death 1 inhibitor combined with chemotherapy compared to chemotherapy alone as first-line treatment in advanced gastric cancer patients: A real-world study.Int Immunopharmacol2025https://conductscience.org/library/papers/40179586PubMed
240,229,646Targeting kinases that regulate programmed cell death: a new therapeutic strategy for breast cancer.J Transl Med2025https://conductscience.org/library/papers/40229646PubMed
340,751,929A comparison of cell death pathways in three different kinds of human lung cancer cell lines following hematoporphyrin derivative-mediated photodynamic therapy.Cancer Biol Ther2025https://conductscience.org/library/papers/40751929PubMed
440,244,424Durable response to nivolumab in combination with regional hyperthermia in a patient with PD-L1-negative metastatic head and neck squamous cell carcinoma.Cancer Immunol Immunother2025https://conductscience.org/library/papers/40244424PubMed
540,369,670New insights into the cold tolerance of upland switchgrass by integrating a haplotype-resolved genome and multi-omics analysis.Genome Biol2025https://conductscience.org/library/papers/40369670PubMed
623,193,258NCBI GEO: archive for functional genomics data sets--update.Nucleic Acids Res2013https://conductscience.org/library/papers/23193258PubMed
740,313,939ALDOC promotes neuroblastoma progression and modulates sensitivity to chemotherapy drugs by enhancing aerobic glycolysis.Front Immunol2025https://conductscience.org/library/papers/40313939PubMed
840,208,185Comprehensive Analysis of GPSM2: From Pan-Cancer Analysis to Experimental Validation.J Cell Mol Med2025https://conductscience.org/library/papers/40208185PubMed
940,819,002Integrative machine learning models predict prostate cancer diagnosis and biochemical recurrence risk: Advancing precision oncology.NPJ Digit Med2025https://conductscience.org/library/papers/40819002PubMed
1032,256,445Liver Transcriptomic Reveals Novel Pathways of Empagliflozin Associated With Type 2 Diabetic Rats.Front Endocrinol (Lausanne)2020https://conductscience.org/library/papers/32256445PubMed

1 to 10 of 37

See all 37 references

Cited by47

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.

PMIDTitleJournalYearIn PapersSource
42,934,562Prognostic value of the neutrophil percentage-to-albumin ratio in patients with IgA nephropathy.BMC Nephrol2026https://conductscience.org/library/papers/42934562PubMed
42,888,188Targeting FEN1 disrupts EIF4A3-mediated MUC1-C autoregulation: a novel strategy to suppress lung adenocarcinoma progression.Cell Death Dis2026https://conductscience.org/library/papers/42888188PubMed
42,855,679MiR-128-3p serves as a diagnostic biomarker in pediatric Mycoplasma pneumoniae pneumonia.BMC Pulm Med2026https://conductscience.org/library/papers/42855679PubMed
42,690,491High expression of CD74 is associated with poor prognosis and tumor immune infiltration in Acute Myeloid Leukemia.Discov Oncol2026https://conductscience.org/library/papers/42690491PubMed
42,589,189Multi-Omics Biomarkers in Head and Neck Squamous Cell Carcinoma: Biological Insights and Clinical Translation: A Narrative Review.Biology (Basel)2026https://conductscience.org/library/papers/42589189PubMed
42,516,377Genetic and cross-species single-cell analyses prioritize CD83 in antigen-presenting cells as a candidate therapeutic target in asthma.Front Immunol2026https://conductscience.org/library/papers/42516377PubMed
42,507,231Construction of a risk model based on folate metabolism-related genes to predict prognosis and immunological characteristics of stomach adenocarcinoma.Discov Oncol2026https://conductscience.org/library/papers/42507231PubMed
42,500,661Berberine restrains the expansion of colorectal cancer organoids by blocking cell cycle progression and reducing lipid synthesis.Front Immunol2026https://conductscience.org/library/papers/42500661PubMed
42,461,346Transcriptomic analysis of lncRNA-miRNA-mRNA competing endogenous RNA regulatory networks in radiation-induced mouse thymic degeneration.Immunol Res2026https://conductscience.org/library/papers/42461346PubMed
42,432,583Uncovering the mechanism of DCLK3 in colorectal cancer progression through WGCNA and machine learning.BMC Cancer2026https://conductscience.org/library/papers/42432583PubMed

1 to 10 of 47

See all 47 cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
PAK25,062PubTator's text mininghttps://conductscience.org/library/genes/5062

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41311809

GET https://conductscience.org/api/papers/v1/41311809/references?page=2

API referenceFor AI assistants